Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 160 | 183 | 175 | 853 | 1,019 |
| Gross Profit | 160 | 183 | 175 | 853 | 1,019 |
| Operating Expenses | 8,823 | 11,336 | 9,748 | 7,697 | 7,108 |
| Operating Income | -8,663 | -11,153 | -9,573 | -6,844 | -6,089 |
| Interest Expense | 157 | 141 | 101 | 58 | 58 |
| Other Income | 389 | 408 | 411 | 411 | 385 |
| Pre-tax Income | -8,431 | -10,886 | -9,263 | -6,491 | -5,762 |
| Net Income Continuous | -8,431 | -10,886 | -9,263 | -6,491 | -5,762 |
| Net Income | $-8,431 | $-10,886 | $-9,263 | $-6,491 | $-5,762 |
| EPS Basic Total Ops | -11.50 | -61.60 | -54.20 | -38.60 | -35.40 |
| EPS Basic Continuous Ops | -11.52 | -61.66 | -54.17 | -38.61 | -35.37 |
| EPS Diluted Total Ops | -11.50 | -61.60 | -54.20 | -38.60 | -35.40 |
| EPS Diluted Continuous Ops | -11.52 | -61.66 | -54.17 | -38.61 | -35.37 |
| EBITDA(a) | $-7,703 | $-10,201 | $-8,733 | $-6,252 | $-5,496 |